GB2076289A - Antiperspirant compositions - Google Patents

Antiperspirant compositions Download PDF

Info

Publication number
GB2076289A
GB2076289A GB8116054A GB8116054A GB2076289A GB 2076289 A GB2076289 A GB 2076289A GB 8116054 A GB8116054 A GB 8116054A GB 8116054 A GB8116054 A GB 8116054A GB 2076289 A GB2076289 A GB 2076289A
Authority
GB
United Kingdom
Prior art keywords
composition
composition according
antiperspirant
combination
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8116054A
Other versions
GB2076289B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB2076289A publication Critical patent/GB2076289A/en
Application granted granted Critical
Publication of GB2076289B publication Critical patent/GB2076289B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

An antiperspirant composition having any of a variety of dosage forms and containing as active antiperspirant materials a combination of an aluminum chloride and an aluminum zirconium hydroxychloride which act synergistically; the product may also contain a combination of magnesium hydroxide (or oxide) and glycine as irritation reducing agents.

Description

SPECIFICATION Antiperspirant compositions This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspirant compositions containing as active ingredients a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychloride individually as antiperspirant materials. We have now found, however, when these materials are employed together they act synergistically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containing as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is also an object of the present invention to provide a method for inhibiting perspiration in subjects by applying to the skin of such subjects an antiperspirant effective amount of compositions containing in combination an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more detailed objects of this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the composition.
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel responding to any one given material. However, when the combination of active ingredients of this invention was used over 93% of the panel participants responded favorably. Additionally, surprisingly high activities were recorded; 88% had superior activity. It has always been believed that the activity mechanisms for different salts differ. What has been discovered here is a combination product that allows activity responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solution is very acidic. We have also found that raising the pH alone is not enough to alleviate the irritation response. However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat; however, it can be essentially eliminated completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may vary somewhat. For the most part, they will constitute between about 5 and about 25% by weight based on the total weight of the composition and preferably 7.5% to about 15% by weight. As used herein, the term "an aluminum chloride" is intended to refer to anhydrous aluminum chloride as well as its hydrated and hydroxide forms e.g. AlCl3.6H2O or Al2(OH)5Cl.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and may be described by the general formula: Al4ZnO(OH)14~n CI, H20 wherein N has the value 0 to 1 4 and x has the value of from 0 to 20. By way of example, mention may be made of compounds of formulas: Al4 ZrO (OH)" Cl3 ; and Al ZrO (OH)o C14 and their corresponding hydrates.
The amount of the aluminum zirconium hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between about 2% to about 20% by weight based on the total weight of the composition and preferably between about 5% to about 10%.
An important feature of the present compositions is the ratio of the aluminum salt and the Al/Zr salt that they contain. This ratio will be in the range of from about 0.5 to about 2; the preferred range being from about 1.25 to about 1.75.
Another important relationship in the present compositions is the metal:chloride mole ratio. It is important that this be less than .9 to retain the ionic character of the complex which is related to its antiperspirant activity. 0 As indicated previously, it is highly advantageous to use a combination of magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combination.will ordinarily be used to adjust the pH in the range of from about 2.5 to about 4.5. The glycine will be employed at a level of from about 0.25% to about 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or oxide) will constitute about 1 % to about 9%. The ratio of glycine to magnesium hydroxide (or oxide) is also an important factor.
This ratio may be in the range of from about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1.0.
The novel combination of antiperspirant materials and the pH adjusting agents described above may be incorporated in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a suitable solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials: A. Roll-On (Lotions and Creams) Actives 25% Emollients 2-4% Surface active agents 2-4% Buffering systems 2-7% Waterq.s. -100% B.Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams Actives 25% Emollients 5-1 5% Suspending agents 2-5% Buffering agents 2-4% Water 100% Aerosol Above 70-85% Propellant 15-30% C. Sticks Actives 25% Gelling agent 2-4% Waxes 5-20% Emollients 5-20% Buffering agents 2-4% Externalphase q.s. 100% *Anhydrous solent The following Examples are given to further illustrate the present invention. It is understood, however, that the invention is not limited thereto.
EXAMPLE 1 Roll-On Lotion (Emulsion o/w) % by weight AICI3. 6H20 15.00 Mg(OH)2 3.75 Al/Zr trichlorohydrate' 10.00 Brij 72 (Polyoxyethylene 2 Stearyl Ether) 3.00 Brij 78 (Polyoxyethylene 20 Stearyl Ether) 1.00 Glycine 0.50 Disodium EDTA 0.10 Polyoxypropylene 1 5 Stearyl Ether (Arlamol E) 4.00 H20 62.65 100.00 EXAMPLE 2 Clear Water Solution (Pump Spray) AlCI3. 6H2O 15.00 Mg(OH)2 3.75 Glycine 0.50 Al/Zr trichlorohydrate' 10.00 H20 65.75 Procetyl AWS (PPG-5 Cetheth 20) 5.00 100.00 EXAMPLE 3 Aerosol Antiperspirant Al/Complex Powder2 6.00 Al/Zr trichlorohydrate1 4.00 Dibutyl phthalate 11.00 Cabosil M-5 0.30 Bentone 34 0.10 Isobutane 78.60 100.00 ' Al4ZrO(OH),1CI3 2 Product prepared by spray drying AICI3;Mg(OH)2 and glycine in the weight ratio of 4:1:.5 EXAMPLE 4 Stick Antiperspirant Al/Complex Powder 1 5.00 Al/Zr trichlorohydrate 1 0.00 Stearyl alcohol 20.00 Dibutyl phthalate 41.00 Procetyl AWS (PPG-5 Cetheth 20) 10.00 Montan wax 4.00 100.00 To demonstrate the fact that the combination of the aluminum choride and the aluminum zirconium hydroxychloride act synergistically as antiperspirants, three compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiperspirant material.Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B contained 10% by weight of aluminum zirconium hydroxychloride and 15% by weight of aluminum chloride; and Composition C contained 25% by weight of aluminum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel. The procedure employed was as described in Federal Register, Vol. 43, Number 196, October 10, 1978 and is called the Gravemetric Axillary Antiperspirant Test.
The results of this test are summarized in Table I below which gives the formulas of Compositions A, B and C as well as the antiperspirant activity measured for each composition. TABLE I A B C Aluminum Zirconium hydroxide Complex 26 10 O Aluminum Chloride - 1 5 25 Emollient 2-4 2-4 2-4 Surface Active Agents 2-4 2-4 2-4 q.s. buffer to pH 3.2 + .3 q.s. water to 100% pH at time of test 3.5 3.2 3.4 Activity 50% 62% 53% As will be seen from the above Table, a 20-25% enhancement of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing from the scope of this invention.

Claims (11)

1. An antiperspirant composition comprising a carrier and as active antiperspirant material a combination of an aluminum chloride and aluminum zirconium hydroxychloride, said combination comprising, based on the total weight of the composition, from about 5% to about 25% by weight of an aluminum chloride and from about 2% to about 20% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to Al/Zr salt in said composition being in the range of from about 0.5 to about 2 and the mole ratio of metal to chloride being less than .9.
2. A composition according to Claim 1 including as a pH adjusting agent a combination of magnesium hydroxide or oxide and glycine, said magnesium hydroxide or oxide constituting from about 1 % to about 9% by weight of said composition and said glycine constituting from about 0.25% to about 5% by weight of said composition.
3. A composition according to Claim 1 or 2 in the form of a lotion.
4. A composition according to Claim 1 or 2 in the form of a solution.
5. A composition according to Claim 1 or 2 in the form of a stick.
6. A composition according to Claim 1 or 2 in the form of an aerosol composition.
7. A composition according to Claim 1 or 2 in the form of a pump spray composition.
8. A composition according to Claim 1 or 2 in the form of a cream or a gel.
9. A composition according to Claim 1 or 2 in the form of a foam.
10. A method for inhibiting perspiration in a subject which comprises applying to the skin of said subject an antiperspirant effective amount of a composition defined in Claims 1 through 9.
11. A composition according to claim 1, substantially as described in any of the foregoing Examples.
GB8116054A 1980-05-27 1981-05-26 Antiperspirant compositions Expired GB2076289B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15311380A 1980-05-27 1980-05-27

Publications (2)

Publication Number Publication Date
GB2076289A true GB2076289A (en) 1981-12-02
GB2076289B GB2076289B (en) 1985-01-09

Family

ID=22545825

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8116054A Expired GB2076289B (en) 1980-05-27 1981-05-26 Antiperspirant compositions

Country Status (17)

Country Link
JP (1) JPS5711908A (en)
AU (1) AU547530B2 (en)
BE (1) BE888975A (en)
CA (1) CA1140470A (en)
CH (1) CH644755A5 (en)
DE (1) DE3120742A1 (en)
FR (1) FR2483230A1 (en)
GB (1) GB2076289B (en)
GR (1) GR75643B (en)
IT (1) IT1170993B (en)
MX (1) MX156358A (en)
NL (1) NL8102540A (en)
NZ (1) NZ197164A (en)
PH (1) PH16329A (en)
PT (1) PT73090B (en)
SE (1) SE452107B (en)
ZA (1) ZA813484B (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673570A (en) * 1985-03-20 1987-06-16 Carter-Wallace, Inc. Gelled antiperspirant compositions
US4774079A (en) * 1980-12-15 1988-09-27 Bristol-Myers Company Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use
US4775528A (en) * 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5114705A (en) * 1983-08-16 1992-05-19 The Gillette Company Antiperspirant composition
US5298640A (en) * 1983-08-16 1994-03-29 The Gillette Company Antiperspirant composition
US5486347A (en) * 1983-08-16 1996-01-23 The Gillette Company Antiperspirant composition
US6136302A (en) * 1999-02-18 2000-10-24 The Procter & Gamble Company Process of making zirconium-aluminum antiperspirant active
US6375937B1 (en) 2000-10-20 2002-04-23 Colgate-Palmolive Company Antiperspirant salts for enhanced cosmetic products
WO2005048966A1 (en) * 2003-11-17 2005-06-02 The Procter & Gamble Company Antiperspirant composition and applicator therefor
US7311898B2 (en) 2002-12-09 2007-12-25 Colgate-Palmolive Company High efficacy, low irritation aluminum salts and related products
US7425321B2 (en) 2001-08-17 2008-09-16 L'oreal S.A. Anhydrous antiperspirant stick
US20120282205A1 (en) * 2009-12-23 2012-11-08 Colgate-Palmolive Company Anhydrous liquid antiperspirant/deodorant composition
US10342749B2 (en) 2014-12-15 2019-07-09 Conopco, Inc. Antiperspirant compositions comprising alums
US20190365616A1 (en) * 2015-11-09 2019-12-05 Gulbrandsen Technologies, Inc. Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc
US10526210B2 (en) 2015-06-30 2020-01-07 Gulbrandsen Technologies, Inc. Method of making high performance activated aluminum sesquichlorohydrate powders

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1153313A (en) * 1980-12-15 1983-09-06 Chung T. Shin Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use
US4606915A (en) * 1981-04-23 1986-08-19 Bristol-Myers Company Antiperspirant combination containing an aluminum halohydrate and a stannic halide
JPH05112440A (en) * 1991-08-09 1993-05-07 Sayuri Takemoto Coating agent for deodorization
WO2015073045A1 (en) * 2013-11-18 2015-05-21 Colgate-Palmolive Company Antiperspirant composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2906668A (en) * 1955-06-13 1959-09-29 Reheis Company Inc Zirconyl and aluminum halohydroxy complex
US3903258A (en) * 1973-08-06 1975-09-02 Gillette Co Zirconium aluminum complexes and method of making the same
US4017599A (en) * 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US3981986A (en) * 1973-11-23 1976-09-21 Armour Pharmaceutical Company Zirconium-aluminum-polyol buffered anti-perspirant complexes
AU8303275A (en) * 1974-07-17 1977-01-20 Armour Pharma Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals
JPS5454863A (en) * 1977-10-03 1979-05-01 Kubota Ltd Stalk and straw conveying apparatus with safety cover

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774079A (en) * 1980-12-15 1988-09-27 Bristol-Myers Company Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use
US5589196A (en) * 1983-08-16 1996-12-31 The Gillette Company Antiperspirant composition
US4775528A (en) * 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5114705A (en) * 1983-08-16 1992-05-19 The Gillette Company Antiperspirant composition
US5298640A (en) * 1983-08-16 1994-03-29 The Gillette Company Antiperspirant composition
US5486347A (en) * 1983-08-16 1996-01-23 The Gillette Company Antiperspirant composition
US5770186A (en) * 1983-08-16 1998-06-23 The Gillette Company Antiperspirant composition
US4673570A (en) * 1985-03-20 1987-06-16 Carter-Wallace, Inc. Gelled antiperspirant compositions
US6136302A (en) * 1999-02-18 2000-10-24 The Procter & Gamble Company Process of making zirconium-aluminum antiperspirant active
US6375937B1 (en) 2000-10-20 2002-04-23 Colgate-Palmolive Company Antiperspirant salts for enhanced cosmetic products
EP1284128B2 (en) 2001-08-17 2010-07-21 L'oreal Anhydrous antiperspirant stick
US7425321B2 (en) 2001-08-17 2008-09-16 L'oreal S.A. Anhydrous antiperspirant stick
US7311898B2 (en) 2002-12-09 2007-12-25 Colgate-Palmolive Company High efficacy, low irritation aluminum salts and related products
WO2005048966A1 (en) * 2003-11-17 2005-06-02 The Procter & Gamble Company Antiperspirant composition and applicator therefor
US7905673B2 (en) 2003-11-17 2011-03-15 The Procter & Gamble Company Antiperspirant composition and applicator therefor
US20120282205A1 (en) * 2009-12-23 2012-11-08 Colgate-Palmolive Company Anhydrous liquid antiperspirant/deodorant composition
US8815222B2 (en) * 2009-12-23 2014-08-26 Colgate—Palmolive Company Anhydrous liquid antiperspirant composition
US10342749B2 (en) 2014-12-15 2019-07-09 Conopco, Inc. Antiperspirant compositions comprising alums
US10526210B2 (en) 2015-06-30 2020-01-07 Gulbrandsen Technologies, Inc. Method of making high performance activated aluminum sesquichlorohydrate powders
US20190365616A1 (en) * 2015-11-09 2019-12-05 Gulbrandsen Technologies, Inc. Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc

Also Published As

Publication number Publication date
PT73090B (en) 1983-02-08
SE8103369L (en) 1981-11-28
CH644755A5 (en) 1984-08-31
AU7092881A (en) 1981-12-03
DE3120742A1 (en) 1982-03-18
GR75643B (en) 1984-08-02
FR2483230A1 (en) 1981-12-04
PT73090A (en) 1981-06-01
BE888975A (en) 1981-11-26
FR2483230B1 (en) 1985-01-04
NZ197164A (en) 1984-08-24
CA1140470A (en) 1983-02-01
PH16329A (en) 1983-09-05
MX156358A (en) 1988-08-12
IT8148527A0 (en) 1981-05-25
SE452107B (en) 1987-11-16
JPS5711908A (en) 1982-01-21
DE3120742C2 (en) 1988-10-27
IT1170993B (en) 1987-06-03
NL8102540A (en) 1981-12-16
ZA813484B (en) 1982-05-26
JPS6412245B2 (en) 1989-02-28
AU547530B2 (en) 1985-10-24
GB2076289B (en) 1985-01-09

Similar Documents

Publication Publication Date Title
GB2076289A (en) Antiperspirant compositions
US4937069A (en) Anhydrous semi-solid antiperspirant suspension
US4053581A (en) Antiperspirant solution containing a mixture of substantially volatile and substantially non-volatile siloxane liquids
US4137306A (en) Anhydrous antiperspirant stick compositions
US4065564A (en) Antiperspirant solution containing a substantially non-volatile siloxane liquid
US4073880A (en) Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid
WO2019206764A1 (en) An antiperspirant composition
US20220257480A1 (en) An antiperspirant composition
JPH0239486B2 (en)
AU2022287610B2 (en) An antiperspirant composition
US4548808A (en) Long-acting anhydrous antiperspirant compositions containing triacetin
EP0319168B1 (en) Antiperspirant compositions
US5135741A (en) Antiperspirant product
EP3941593B1 (en) An antiperspirant composition comprising reactive salts
EP0272354A1 (en) Antiperspirant product
EP3941594B1 (en) An antiperspirant composition comprising reactive salts
US20230293400A1 (en) An Antiperspirant Composition
US5194249A (en) Non-whitening antiperspirant compositions
JP2018203683A (en) Antiperspirant composition
NZ199507A (en) Antiperspirant compositions containing an aluminium halohydrate and a stannic halide
EP4259066B1 (en) An antiperspirant composition
EP3482741B1 (en) Antimicrobial antiperspirant compositions
US20220054374A1 (en) An antiperspirant composition comprising inorganic polyionic cluster
WO2019058904A1 (en) Antiperspirant composition
JP2019055937A (en) Antiperspirant composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee